Science Explorer Back to mapMap
Discussion
Researcher · Eli Lilly (Germany) · Germany

Henrik Depenbrock

Henrik Depenbrock publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Molecular Biology, on topics such as Lung Cancer Treatments and Mutations, Colorectal Cancer Treatments and Studies and Lung Cancer Research Studies.

OpenAlex
World rank
#3,852,581
of 7,710,434 ranked researchers
Rank in Germany
#193,400
of 364,343
Works
58
Citations
1.3k
Citations per work
22.9
h-index
16
i10-index 20Top 33% in Oncology
Henrik Depenbrock

What does Henrik Depenbrock research?

Henrik Depenbrock's work is mostly in Medicine (59%), Biochemistry, Genetics and Molecular Biology (11%), Chemistry (4%).

Health Sciences: 34 works · 58.9% of their workMedicine: 34 works · 58.9% of their workOncology: 19 works · 32.3% of their workPulmonary and Respiratory Medicine: 12 works · 21.5% of their workRadiology, Nuclear Medicine and Imaging: 3 works · 5.1% of their workEverything else: 15 works · 26.5% of their workLife Sciences: 6 works · 10.8% of their workBiochemistry, Genetics and Molecular Biology: 6 works · 10.8% of their workMolecular Biology: 4 works · 7.6% of their workCancer Research: 2 works · 3.2% of their workPhysical Sciences: 2 works · 3.8% of their workChemistry: 2 works · 3.8% of their workOrganic Chemistry: 2 works · 3.8% of their workTHEIR WORKHenrik Depenbrock58works
Life Sciences11%Physical Sciences4%Health Sciences59%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine3458.9%
  2. Everything else1526.5%
    1. Biochemistry, Genetics and Molecular Biology610.8%
    1. Chemistry23.8%
  1. 1Oncology32% of their works
  2. 2Pulmonary and Respiratory Medicine22% of their works
  3. 3Molecular Biology8% of their works
  4. 4Radiology, Nuclear Medicine and Imaging5% of their works
  5. 5Organic Chemistry4% of their works
  6. 6Cancer Research3% of their works

Research topics

Which keywords describe Henrik Depenbrock's research?

The keywords of their largest research topics: Chemotherapy, Clinical Trials, Targeted Therapy, ALK Inhibitors, EGFR Mutations, Cetuximab, Genomic Profiles and KRAS Mutations.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Chemotherapy375 topics
  2. Clinical Trials342 topics
  3. Targeted Therapy342 topics
  4. ALK Inhibitors251 topic
  5. EGFR Mutations251 topic
  6. Cetuximab91 topic
  7. Genomic Profiles91 topic
  8. KRAS Mutations91 topic
  9. Small-Cell Lung Cancer91 topic
  10. Breast Cancer81 topic
  11. HER281 topic
  12. Immune Checkpoint Blockade71 topic
  13. PD-1 and PD-L171 topic
  14. DNA61 topic
  15. Topoisomerases61 topic
  16. CT Screening51 topic
  17. Chemotherapy-Induced Peripheral Neuropathy51 topic
  18. Lung Cancer51 topic
  19. Taxanes51 topic

Where does Henrik Depenbrock work?

Henrik Depenbrock's main affiliation in the publication record is Eli Lilly (Germany), Germany.

How many publications and citations does Henrik Depenbrock have?

OpenAlex counts 58 works and 1,329 citations for Henrik Depenbrock, an h-index of 16, ranking #3,852,581 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Henrik Depenbrock. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.